Julphar’s new medicines improve the control of blood glucose levels in the body. Jeff Topping / The National
Julphar’s new medicines improve the control of blood glucose levels in the body. Jeff Topping / The National
Julphar’s new medicines improve the control of blood glucose levels in the body. Jeff Topping / The National
Julphar’s new medicines improve the control of blood glucose levels in the body. Jeff Topping / The National

Julphar adds two new drugs to its diabetes portfolio


  • English
  • Arabic

Gulf Pharmaceutical Industries, known as Julphar, has launched two drugs for managing type 2 diabetes.

It is part of a 2014 licensing and co-marketing agreement with the US company Merck Sharp & Dohme, Abu Dhabi-listed Julphar said yesterday.

“The launch of Xelevia and Velmetia is part of our continuing mission to develop Julphar diabetes portfolio, to support the healthcare community in the region,” said Dr Hosam Badr, the marketing director at Julphar.

Both medicines help improve the control of blood glucose (sugar) levels in the body when combined with a healthy diet and exercise.

Figures from the International Diabetes Federation show that more than 19 per cent of the population in the UAE has type 2 diabetes – ranking 16th worldwide.

An unhealthy, inactive lifestyle and weight gain are the leading causes of type 2 diabetes.

Studies have shown that people with diabetes have a six times higher risk of cardiovascular disease and stroke.

In 2019, the UAE’s pharmaceutical expenditure is expected to reach Dh13.97 billion, growing at an average of 8 per cent annually from Dh10.32bn last year, according to a report in February from the research company BMI.

The manufacturer of gen­eric medicines reported a net profit of Dh54.8 million in the second quarter of the year, compared to Dh54.3m a year earlier.

Julphar shares closed unchanged yesterday at Dh2.18.

business@thenational.ae

Follow The National's Business section on Twitter

Changing visa rules

For decades the UAE has granted two and three year visas to foreign workers, tied to their current employer. Now that's changing.

Last year, the UAE cabinet also approved providing 10-year visas to foreigners with investments in the UAE of at least Dh10 million, if non-real estate assets account for at least 60 per cent of the total. Investors can bring their spouses and children into the country.

It also approved five-year residency to owners of UAE real estate worth at least 5 million dirhams.

The government also said that leading academics, medical doctors, scientists, engineers and star students would be eligible for similar long-term visas, without the need for financial investments in the country.

The first batch - 20 finalists for the Mohammed bin Rashid Medal for Scientific Distinction.- were awarded in January and more are expected to follow.

Real estate tokenisation project

Dubai launched the pilot phase of its real estate tokenisation project last month.

The initiative focuses on converting real estate assets into digital tokens recorded on blockchain technology and helps in streamlining the process of buying, selling and investing, the Dubai Land Department said.

Dubai’s real estate tokenisation market is projected to reach Dh60 billion ($16.33 billion) by 2033, representing 7 per cent of the emirate’s total property transactions, according to the DLD.

Paatal Lok season two

Directors: Avinash Arun, Prosit Roy 

Stars: Jaideep Ahlawat, Ishwak Singh, Lc Sekhose, Merenla Imsong

Rating: 4.5/5